Tectonic Therapeutic | AVRO - Capital Social Ordinario

Precio De Mercado
28.54
Cambio Diario
0.10 0.35%
Mensual
-8.11%
Anual
35.32%
Q2 Expectativa
27.93




Capital Social Ordinario Cambio Fecha
Akebia Therapeutics USD 265.42M 199K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Celltrion KRW 218.78M 1.5M 2025-09
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Gilead Sciences USD 1.24B 1000K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Kangmei Pharma CNY 13.83B 34.97M 2025-09
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
MacroGenics USD 63.32M 60K 2025-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Pharma Mar EUR 17.36M 214.99K 2025-12
Qiagen NV USD 216.56M 284.67K 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Sarepta Therapeutics USD 104.96M 196K 2025-12
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Takeda JPY 1.58B 2K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2025-09